CLINIC-OWNED MEDICALLY INTEGRATED DISPENSARIES IN THE UNITED STATES; REGULATORY PATHWAYS, DIGITAL WORKFLOW INTEGRATION, AND COST-BENEFIT IMPACT ON PATIENT ADHERENCE

The establishment of medically integrated dispensaries (MIDs) within clinical settings represents a transformativemodel in U.S. outpatient care, enabling real-time access to medication, personalized pharmacist consultations, andimproved therapeutic adherence. This paper explores the operational, regulatory, and technological landscape ofclinic-owned MIDs, focusing on their implications for value-based care and patient-centric service delivery. Whilethese models are gaining traction in oncology, rheumatology, and chronic disease management clinics, theiradoption is influenced by complex state-level pharmacy regulations, reimbursement constraints, and EHRinteroperability challenges. The first section analyzes the regulatory frameworks that govern MIDs, includingstate pharmacy board licensure requirements, Medicare Part D considerations, and compliance with Drug SupplyChain Security Act (DSCSA) mandates. The paper then explores the role of digital integration, highlighting howelectronic prescribing, inventory management, and real-time benefit tools enable seamless clinical-pharmacycommunication and reduce medication errors. Emphasis is placed on the technical architecture required for EHR–dispensary interoperability and data-driven reporting. Through a cost-benefit lens, the study presents evidencefrom health systems and specialty clinics where MIDs have led to increased medication adherence, lower totalcost of care, and reduced patient abandonment rates. It also evaluates risks, including conflicts of interest andpotential overutilization. The analysis concludes with a framework for implementing MIDs in diverse caresettings, recommending cross-disciplinary collaboration, digital maturity alignment, and robust complianceprotocols. Ultimately, clinic-owned MIDs serve as a strategic enabler of patient-centered care, especially inchronic and high-acuity therapeutic areas